Epidemiology of cardiogenic shock and cardiac arrest complicating non-ST-segment elevation myocardial infarction:
Saraschandra Vallabhajosyula1,2,3, Jacob C Jentzer1,2, Abhiram Prasad1
1Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Insights
The combination of cardiogenic shock (CS) and cardiac arrest (CA) significantly increases mortality and organ failure in non-ST-segment elevation myocardial infarction (NSTEMI) patients. This dual complication leads to worse outcomes than either condition alone.
Area of Science:
- Cardiology
- Critical Care Medicine
- Health Services Research
Background:
- Non-ST-segment elevation myocardial infarction (NSTEMI) is a common presentation of acute coronary syndrome.
- Cardiogenic shock (CS) and cardiac arrest (CA) are severe complications that can arise during NSTEMI.
- The combined impact of CS and CA on NSTEMI outcomes is not fully elucidated.
Purpose of the Study:
- To evaluate the impact of the combination of cardiogenic shock (CS) and cardiac arrest (CA) in patients with non-ST-segment elevation myocardial infarction (NSTEMI).
- To compare outcomes between NSTEMI patients with CS only, CA only, both CS and CA, and neither complication.
Main Methods:
- Analysis of adult NSTEMI admissions from the National Inpatient Sample database (2000-2017).
- Stratification of patients based on the presence of CS and/or CA.
- Comparison of in-hospital mortality, early coronary angiography rates, hospitalization costs, and length of stay.
Main Results:
- NSTEMI admissions with both CS and CA showed significantly higher rates of multiorgan failure compared to CS alone or CA alone.
- The CS + CA cohort experienced substantially higher in-hospital mortality (aOR 4.12) compared to CS alone, CA alone, or no CS/CA.
- NSTEMI patients with CS (alone or with CA) had increased hospitalization costs and longer hospital stays.
Conclusions:
- The combination of CS and CA in NSTEMI admissions is associated with a significantly higher risk of acute non-cardiac organ failure.
- NSTEMI patients experiencing both CS and CA have markedly worse in-hospital mortality rates compared to those with either complication individually.
- The presence of CS, particularly when combined with CA, represents a critical factor driving adverse outcomes, increased costs, and prolonged hospitalizations in NSTEMI.
Aims:
This study aims to evaluate the impact of the combination of cardiogenic shock (CS) and cardiac arrest (CA) complicating non-ST-segment elevation myocardial infarction (NSTEMI).
Methods And Results:
Adult (>18 years) NSTEMI admissions using the National Inpatient Sample database (2000 to 2017) were stratified by the presence of CA and/or CS. Outcomes of interest included in-hospital mortality, early coronary angiography, hospitalization costs, and length of stay. Of the 7 302 447 hospitalizations due to NSTEMI, 147 795 (2.0%) had CS only, 155 522 (2.1%) had CA only, and 41 360 (0.6%) had both CS and CA. Compared with 2000, the adjusted odds ratios (ORs) and 95% confidence interval (CIs) for CS, CA, and both CS and CA in 2017 were 3.75 (3.58-3.92), 1.46 (1.42-1.50), and 4.52 (4.16-4.87), respectively (all P < 0.001). The CS + CA (61.2%) cohort had higher multiorgan failure than CS (42.3%) and CA only (32.0%) cohorts, P < 0.001. The CA only cohort had lower rates of overall (52% vs. 59-60%) and early (17% vs. 18-27%) angiography compared with the other groups (all P < 0.001). CS + CA admissions had higher in-hospital mortality compared with those with CS alone (aOR 4.12 [95% CI 4.00-4.24]), CA alone (aOR 1.69 [95% CI 1.65-1.74]), or without CS/CA (aOR 22.66 [95% CI 22.06-23.27]). The presence of CS, either alone or with CA, was associated with higher hospitalization costs and longer hospital length of stay.
Conclusions:
The combination of CS and CA is associated with higher rates of acute non-cardiac organ failure and in-hospital mortality in NSTEMI admissions as compared with those with either CS or CA alone.
More Related Videos
Related Concept Videos
Introduction Cardiac Emergencies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Cardiopulmonary Resuscitation IV: Pharmacological Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiopulmonary Resuscitation III: AED Use


